Histamine up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils

Inflammation Research

Volumn 49, Issue 11, 2000, Pages 600-609

  Dasi F J ^a   Ortiz, J L ^a   Cortijo, J ^a   Morcillo, E J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Histamine; Human neutrophils; Phosphodiesterase 4; Phosphodiesterase isoenzymes; Up regulation

Indexed keywords

CYCLIC AMP; CYTOCHROME C; HISTAMINE; MESSENGER RNA; PHOSPHODIESTERASE IV; PROSTAGLANDIN E2; SUPEROXIDE; ZYMOSAN;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; DESENSITIZATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME KINETICS; HUMAN; HUMAN CELL; NEUTROPHIL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC AMP; DINOPROSTONE; HISTAMINE; HUMANS; KINETICS; NEUTROPHIL ACTIVATION; NEUTROPHILS; OPSONIN PROTEINS; PROTEIN ISOFORMS; RNA, MESSENGER; SUPEROXIDES; TRANSCRIPTION, GENETIC; ZYMOSAN;

EID: 0033710087     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050637     Document Type: Article

References (45)

1. Phosphodiesterase isozymes. Molecular targets for novel antiasthma agents
2. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase
3. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase
4. Multiple cyclic nucleotide phosphodiesterases
5. Subtypes of the type 4 cAMP phosphodiesterases: Structure, regulation and selective inhibition
6. Phosphodiesterase 4 and tolerance to β2-adrenoceptor agonists in asthma
7. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity
8. Expression and regulation of human and rat phosphodiesterase type IV isogenes
9. 2
10. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells
11. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing nRNA and protein for phosphodiesterases 4A and 4B
12. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant
13. Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. Potential role in β2-adrenoceptor desensitization
14. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes
15. Cellular infiltration of the airways in asthma of varying severity
16. Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai
17. Salbutamol up-regulates PDE IV activity in human neutrophils
18. Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils
19. Histamine as a mediator of allergic and inflammatory reactions
20. Decreased H2 histamine response of granulocytes of asthmatic patients
21. Functional desensitization due to stimulation of cyclic AMP-phosphodiesterase in human mononuclear leukocytes
22. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: A possible mechanism for cyclic AMP-agonist hyporresponsiveness
23. Histamine induced elevation of cyclic AMP phosphodiesterase activity in human monoytes
24. Superoxide generation and its modulation by adenosine in the neutrophils of subjects with asthma
25. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: Comparison with rolipram, SKF94120 and levcromakalim
26. Studies on the cardiac actions of flosequinan in vitro
27. Cyclic nucleotide phosphodiesterase (PDE)
28. Investigation into the role of phosphodiesterase IV in broncho-relaxation, including studies with human bronchus
29. Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes
30. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
31. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro
32. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils
33. Beta-2-Agonists have antioxidant function in vitro
34. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase
35. Histaminemia after aspirin challenge in aspirin-sensitive asthmatics
36. Histamine levels in bronchial mucus and in blood
37. Indomethacin enhances response of human bronchus to antigen
38. Histamine inhibition of neutrophil lysosomal enzyme release: An H2 histamine receptor response
39. Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP
40. Polymorphonuclear leukocyte histamine receptors: Occurrence in cell surface clusters and their redistribution during locomotion
41. 2-receptors
42. Histamine H-1 binding site on human polymorphonuclear leukocytes
43. Influence of histamine H3-antagonists on human leukocytes
44. Neutrophil adhesion to histamine stimulated cultured endothelial cells is primarily mediated via activation of phospholipase C and nitric oxide synthase isozymes
45. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils